Induction of CD8+ T-cell responses against subunit antigens by the novel cationic liposomal CAF09 adjuvant.
about
Understanding natural herpes simplex virus immunity to inform next-generation vaccine designLiposome-Based Adjuvants for Subunit Vaccines: Formulation Strategies for Subunit Antigens and ImmunostimulatorsImmunogenicity of HLA Class I and II Double Restricted Influenza A-Derived PeptidesLow Antigen Dose in Adjuvant-Based Vaccination Selectively Induces CD4 T Cells with Enhanced Functional Avidity and Protective Efficacy.Orchestration of pulmonary T cell immunity during Mycobacterium tuberculosis infection: immunity interruptus.Cationic liposomes loaded with a synthetic long peptide and poly(I:C): a defined adjuvanted vaccine for induction of antigen-specific T cell cytotoxicity.Intracellular Cytokine Staining and Flow Cytometry: Considerations for Application in Clinical Trials of Novel Tuberculosis VaccinesEstablishing the pig as a large animal model for vaccine development against human cancerThe administration route is decisive for the ability of the vaccine adjuvant CAF09 to induce antigen-specific CD8(+) T-cell responses: The immunological consequences of the biodistribution profile.Systematic Investigation of the Role of Surfactant Composition and Choice of oil: Design of a Nanoemulsion-Based Adjuvant Inducing Concomitant Humoral and CD4+ T-Cell Responses.CD8 T cells and Mycobacterium tuberculosis infection.Humanized NOG mice as a model for tuberculosis vaccine-induced immunity: a comparative analysis with the mouse and guinea pig models of tuberculosis.Innate signaling by mycobacterial cell wall components and relevance for development of adjuvants for subunit vaccines.Macrophage Inducible C-Type Lectin As a Multifunctional Player in Immunity.Broadening CD4+ and CD8+ T Cell Responses against Hepatitis C Virus by Vaccination with NS3 Overlapping Peptide Panels in Cross-Priming Liposomes.A stable nanoparticulate DDA/MMG formulation acts synergistically with CpG ODN 1826 to enhance the CD4⁺ T-cell response.Robust antibody and CD8+ T-cell responses induced by P. falciparum CSP adsorbed to cationic liposomal adjuvant CAF09 confer sterilizing immunity against experimental rodent malaria infection.Sequestering of damage-associated molecular patterns (DAMPs): a possible mechanism affecting the immune-stimulating properties of aluminium adjuvants.Novel Adjuvant Based on the Pore-Forming Protein Sticholysin II Encapsulated into Liposomes Effectively Enhances the Antigen-Specific CTL-Mediated Immune Response.Synergy effects of Polyinosinic-polycytidylic acid, CpG oligodeoxynucleotide, and cationic peptides to adjuvant HPV E7 epitope vaccine through preventive and therapeutic immunization in a TC-1 grafted mouse model.Effects of Cross-Presentation, Antigen Processing, and Peptide Binding in HIV Evasion of T Cell Immunity.Viruslike Particles Encapsidating Respiratory Syncytial Virus M and M2 Proteins Induce Robust T Cell Responses.The Multirole of Liposomes in Therapy and Prevention of Infectious Diseases.Induction of Cytotoxic T-Lymphocyte Responses Upon Subcutaneous Administration of a Subunit Vaccine Adjuvanted With an Emulsion Containing the Toll-Like Receptor 3 Ligand Poly(I:C).Adjuvanted influenza vaccinesTargeting the Mincle and TLR3 receptor using the dual agonist cationic adjuvant formulation 9 (CAF09) induces humoral and polyfunctional memory T cell responses in calvesCationic Liposomes: A Flexible Vaccine Delivery System for Physicochemically Diverse Antigenic Peptides
P2860
Q26741484-E64699BF-E39F-48F6-AC5A-448406B523AEQ26765446-7489DC5D-2525-4035-B5E9-577D62C88557Q28552077-3DC0D176-C39D-494D-9547-7E106D19C107Q33567970-8F9EB350-AA4C-41BB-8630-14612AA7E11AQ34603687-C16B95DD-FA1C-4718-892A-1E191CAC001EQ34871801-DE0FC5EF-3DF4-4A39-9904-7C478A40C01CQ35772893-A4254A93-303D-400A-97F5-847957527BD3Q36097327-8B6EDB1F-C3DD-4C13-968F-C82DE758FD91Q37294444-1C466A33-488F-4DDB-A3DC-3D710B3073E8Q37834166-E5BA047F-7264-41B3-8EED-DF1F9A0114FBQ38445065-4A9DD5CF-E79E-4543-9A9A-84BCBAD3C53DQ38787325-3BD2BEF0-4216-4EF5-AFD9-755008191BE4Q39748955-F555E494-3B27-4252-875D-76228AF7F3D3Q40101167-E873A53E-9111-48EE-94E5-8B202F82BF82Q40226233-F6D30859-590F-4290-8204-159FA6BCB273Q41588441-F3EA2370-DD21-4CC1-8AE0-4FD1583C08D7Q41722577-558C9A98-8646-499C-8AC1-DD67D709F25CQ47123344-8BE2E74B-FEB8-45D6-9FEA-14B5E21761AEQ47142328-49DE3013-A5F4-41B5-8E2B-38A8C1ECFA7EQ47224779-71FCE762-41A2-4EA5-AB90-88BE4E6C6C1AQ47548620-6A4EBCEF-4BCD-40E8-AE81-1B71F03F7271Q49187990-F1B8DC64-5E0F-4E3D-9BC1-1DA5E650A964Q50124824-12360A32-3BBC-434B-AA9A-FDE3C1CDE244Q54211947-D359AA85-7BC9-4FF1-9FED-DE2752B8EBBEQ57094841-1D64151D-F4D1-49DD-BDCD-E366B1A771F7Q58494322-C375FBDE-83E5-45A5-AAD8-A63EA8402193Q58745887-B367B917-2543-4952-A720-95BD42BE883C
P2860
Induction of CD8+ T-cell responses against subunit antigens by the novel cationic liposomal CAF09 adjuvant.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Induction of CD8+ T-cell respo ...... onic liposomal CAF09 adjuvant.
@en
Induction of CD8+ T-cell respo ...... onic liposomal CAF09 adjuvant.
@nl
type
label
Induction of CD8+ T-cell respo ...... onic liposomal CAF09 adjuvant.
@en
Induction of CD8+ T-cell respo ...... onic liposomal CAF09 adjuvant.
@nl
prefLabel
Induction of CD8+ T-cell respo ...... onic liposomal CAF09 adjuvant.
@en
Induction of CD8+ T-cell respo ...... onic liposomal CAF09 adjuvant.
@nl
P2093
P50
P1433
P1476
Induction of CD8+ T-cell respo ...... onic liposomal CAF09 adjuvant.
@en
P2093
Jon Hansen
Jonathan Filskov
Karen Smith Korsholm
Kasper Karlsen
Marianne Mikkelsen
P304
P356
10.1016/J.VACCINE.2014.05.050
P407
P577
2014-05-28T00:00:00Z